Sponsors
Piper Jaffray
Piper Jaffray Ltd. is a leading investment bank servicing the UK small/mid-cap health care sector. The firm is the retained financial adviser and/or broker to 58% of the companies comprising the techMARK mediscience index. Piper Jaffray Ltd. makes markets in 28 LSE full and AIM-listed health care stocks, has research coverage of 54 European health care stocks and the ability to distribute this research product both in Europe and in the United States. The firm has extensive experience in the health care and technology sectors.
Having been involved in 14 of the top 40 European biotech equity financing transactions (six as bookrunner) since the beginning of 2006 raising over €1,500m, Piper Jaffray Ltd. is a leading adviser of life science transactions with a 28% market share in European biotech equity financing. Over the same period, the firm was responsible for 7 out of the top 10 secondary equity financing raised in the UK biotech sector. Piper Jaffray Ltd. has advised on 16 M&A transactions since the beginning of 2006, 14 of which were cross-border.
Piper Jaffray Ltd. is a subsidiary of Piper Jaffray Companies, a leading, international middle market investment bank and NYSE-listed institutional securities firm with a market cap of c. US$800 million. It offers investment banking, equity research and equity sales and trading within Europe to middle market corporations, private equity groups and institutional investors. Piper Jaffray Ltd. is authorised and regulated by the Financial Services Authority and is a member of the London Stock Exchange.
Piper Jaffray is proud to sponsor the European mediscience awards dinner.
For further information: www.piperjaffray.co.uk
M:Communications
M:Communications was founded in 2002 and has quickly become Europe's most sought after financial and corporate communications agency. M:, with a global network of offices in London, New York, Dubai, Moscow and Hong Kong, represents some of the world's most successful international businesses and in particular, in Europe, has served or is retained by 60 of the EURO300. M:'s highly experienced senior consultants advise clients across a whole range of corporate and financial communications including reputation management, profile raising, media management, transactions, investor relations and crisis response.
M:'s sector specialist healthcare team has more than fifteen years of experience from the pharmaceutical industry and leading communications agencies. The team is highly experienced in working alongside international healthcare clients, both public and private, across the entire range of sub-sectors. M: prides itself on providing a high quality and proactive approach to clients and has quickly become established as a leading healthcare consultancy.
The healthcare team at M: is pleased to be sponsoring this year's European Mediscience Awards Dinner and we hope you enjoy the evening.
For more information please visit www.mcomgroup.com, call us on +44 207 920 2345 or send an e-mail to healthcare@mcomgroup.com.
Capital MS&L
Capital MS&L is a leading global consultancy specialising in international corporate and financial communications. Our key focus markets are: Life Sciences, Financial Services and Emerging Markets.
Capital's Life Sciences team has a proven track record in developing and implementing strategic communication programmes for European companies across the healthcare and biotech sectors.
Our integrated communications approach, combining public relations and investor relations, is not only based on in-depth knowledge and understanding of international media but also extensive relationships with sell-side analysts, corporate finance and banking executives, venture capitalists, private equity firms and institutional investors.
We have specific expertise in helping private and public life sciences companies to position, explain and develop their stories. An integral part of our service is to successfully generate positive coverage in influential life sciences media for our clients and to leverage our excellent relationships with key influencers in the sector to deal appropriately and responsibly with adverse events.
Our specialist team is led by Mary Clark and combines industry expertise with corporate communications, media outreach and investor relations. Our strengths lie in the ability to advise, develop and implement integrated IR and PR programmes, our unparalleled network of contacts across the investment community and the senior counsel of an experienced highly committed team.
As part of MS&L worldwide, we offer our clients global access and reach, providing communications support in every major city around the world.
Capital MS&L is proud to sponsor the European Mediscience Awards Dinner.
For further information: www.capitalmsl.com and lifescienceteam@capitalmsl.com
MATRIX Corporate Capital LLP
The investment banking business of Matrix Group is a client focused, advisory, capital raising and securities sales, trading and research firm. We bring together considerable experience, knowledge and access to meet and match the strategic ambitions of growing companies and the performance needs of investing institutions. Today Matrix has a 90 strong investment banking team advising over 70 retained clients and serving the sales, trading and research needs of more than 140 institutional customers.
The integrated Healthcare team at Matrix have a wealth of experience in the sector with 18 IPOs and 43 secondary raisings, totalling over $3.5bn of combined experience. Our high quality research-driven franchise provides dedicated sector expertise in all the client facing aspects of the business. Matrix is focused on building a stable of long-term retained clients (both as NOMAD and Broker) in the fields of speciality pharmaceuticals, vaccines, contracted research/manufacturing services, diagnostics and alternative energy, and across a full spectrum of clients from private equity specialists to public market generalists and hedge funds.
In addition to specialising in healthcare, our strengths lie in sectors including oil and gas, mining, clean-tech, power and new energy, building materials and more recently financial services, leisure, business services and drinks. Matrix now covers around 90 stocks, balanced between small, mid and large cap.
The investment banking business is part of Matrix Group, one of the largest and most successful privately owned financial services businesses in the UK with over £3 billion of assets under management and more than 230 professionals employed across four divisions: asset management, investment banking, property and specialised finance. Since inception in 1987, Matrix has raised over £9.5 billion of assets for investments across these business areas.
The Design Portfolio Marketing Services
Established in 1991, The Design Portfolio Marketing Services has developed into one of Europe's leading Corporate Communications consultancies. It works with over 120 quoted company clients, assisting them with their communication strategies, developing key messages and helping them build long term relationships with shareholders and potential shareholders. Key areas of expertise include designing and producing annual reports (both printed and online), analyst presentations, corporate and IR websites, corporate responsibility communications, internal communications and external communications such as webcasting and audiocasting. All of these services are available from our network of offices throughout the UK.
We work closely with a number of clients in the mediscience sector, where good communication and value for money are more important than ever.
The Design Portfolio Marketing Services is part of the flathill communications group plc.
Shares Magazine
Shares is the leading weekly publication for high net worth private investors and stock market professionals and as such is read weekly by thousands of private investors, analysts, fund managers, stockbrokers and company directors. Since its launch in 1999 Shares has developed a strong following from those who invest or trade regularly on the stock market. The Shares team of expert writers are highly regarded in the City and their comment frequently influences the market's view of individual companies.
The magazine's easy-to-read style and depth of analysis has made it the indispensable weekly read for those actively investing in the stock market today. And following a review of the content in 2009, we broadened the range of assets classes to include commodities and FX, expand our coverage the of different investment instruments and introduced additional editorial features in order to extend its readership within the stock market, investor and trader communities.
To subscribe please visit www.sharesmagazine.co.uk/medi or for information on advertising contact Richard Collins rcollins@msm.co.uk
NASDAQ OMX Group
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) is the world's largest exchange company. It delivers trading, exchange technology and public company services across six continents, with more than 3,600 listed companies. NASDAQ OMX offers multiple capital raising solutions to companies around the globe, including its U.S. listings market, NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX First North, and the U.S. 144A sector. The company offers trading across multiple asset classes including equities, derivatives, debt, commodities, structured products and exchange-traded funds. NASDAQ OMX technology supports the operations of over 70 exchanges, clearing organizations and central securities depositories in more than 50 countries. NASDAQ OMX Nordic and NASDAQ OMX Baltic are not legal entities but describe the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius.
For more information about NASDAQ OMX, visit http://www.nasdaqomx.com. Please follow NASDAQ OMX on Facebook and Twitter
College Hill
College Hill is a leading international business communications agency with an exceptionally strong focus in the Mediscience sector.
College Hill Life Sciences has specialists across financial, corporate, healthcare and marketing communications, and integrates design into its communications mix.
Led by Managing Partner Sue Charles, the team has further strengthened its financial expertise by appointing Melanie Toyne-Sewell as Head of Financial PR at the beginning of this year.
College Hill Life Sciences offers seamless global outreach with teams located in the UK, US, Germany and has experience of working with a range of businesses from start-ups to leading multinational corporations. Its client base spans pharma, biotechnology, medical devices, diagnostics, healthcare, laboratory supplies and service providers in addition to venture capitalists, recruitment companies, not-for-profit and academic organisations and science-associated bodies.
College Hill Life Sciences is part of College Hill – which acquired Northbank Communications in 2007.
Buchanan Communications
Buchanan Communications is a leading financial public relations agency with a core specialism in healthcare. Its exciting international client portfolio ranges from highly profitable pharmaceutical and services businesses through to innovative drug discoverers. A deep-rooted knowledge of the healthcare industry is the key to the success of Buchanan's relationships with its clients and sector commentators. The Buchanan healthcare team brings long-term experience in IPOs, M&A, fund raisings and crisis management but is focused day-to-day on proactive advisory support.
For further information: www.buchanan.uk.com